Vimarsana
Biggest News Aggregation in the World

Page 8 - Thomas Hoffmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Hoffmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Hoffmann Today - Breaking & Trending Today

Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session ... - Vimarsana News

Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session ... ZENTALIS PHARMACEUTICALSApril 10, 2021 GMT ZN-c3 demonstrated single agent activity, generating Exceptional Responses in a range of heavily pre-treated solid tumors ZN-c3 was safe and well-tolerated Identified recommended Phase 2 dose for ZN-c3 to be 300 mg QD with continuous dosing Announces plan to start Phase 1/2 osteosarcoma trial in Q3 2021 Company to host webcast event with key opinion leaders on...

Source: apnews.com
KAHR Announces Exclusive Licensing Agreement with Thomas Jefferson University for Novel Platform of Bi- and Tri-Specific Fusion Proteins for Cancer Immunotherapy - Vimarsana News

KAHR Announces Exclusive Licensing Agreement with Thomas Jefferson University for Novel Platform of Bi- and Tri-Specific Fusion Proteins for Cancer Immunotherapy

Share this article Share this article JERUSALEM, April 1, 2021 /PRNewswire/ -- KAHR, a cancer immunotherapy company developing novel multifunctional immuno-recruitment proteins, announced today that it has entered into a licensing agreement with Thomas Jefferson University -- a national doctoral research university -- and its clinical enterprise, Jefferson Health, located in Philadelphia, PA. Under the agreement, Thomas Jefferson University is granting KAHR an exclusive license to develop and commercialize multiple new drug candidates including DSP502, a TIGITxPD1 fusion protein, and DSP216...

Colorado Campworks' All-Electric Teardrop Trailer NS-1 Reinvents Camping - Vimarsana News

Colorado Campworks' All-Electric Teardrop Trailer NS-1 Reinvents Camping

Colorado Campworks’ All-Electric Teardrop Trailer NS-1 Reinvents Camping 14 Mar 2021, 6:55 UTC · by “Still camping,” reads the Nomad’s description on the official website. “We took camping and aimed to make it better. Instead we may have reinvented it.” A look at the Nomad shows that, indeed, they may have done just that. The Nomad’s story starts back when Colorado Campworks founder Thomas Hoffmann was a student at the University of Colorado: it was his senior design project, New Atlas reports. The idea was shelved after graduation, as Hoffmann went to work for EarthRoame...

Hopkinton drops 41-40 heartbreaker to Gilford in D-III boys' hoop final - Vimarsana News

Hopkinton drops 41-40 heartbreaker to Gilford in D-III boys' hoop final

Hopkinton drops 41-40 heartbreaker to Gilford in D-III boys’ hoop final Hopkinton's Brendan Elrick (left) posts up against Gilford's Malik Reese during the NHIAA Division III boys' basketball championship on Saturday, March 13, 2021, in Laconia. Elrick had 12 points and three blocks, but Gilford won, 41-40. JEFF SULLIVAN—sullivaneventphotography.com Hopkinton's Brendan Elrick attempts to block a shot against Gilford during the NHIAA Division III boys' basketball championship on Saturday, March 13, 2021, in Laconia. Elrick had 12 points and three blocks, but Gilford won, 41-40. JEFF SULLI...

Solar-powered off-road teardrop trades propane for electric camping - Vimarsana News

Solar-powered off-road teardrop trades propane for electric camping

We've seen a few electric camping trailers on the global market, and Colorado Campworks presents one of the first we've seen in the US. Its NS-1 is an off-road teardrop built to rely solely on electric power out in the wild, no need for LPG.